ADMA Biologics, Inc (ADMA)

Etorro trading 970x250
ADMA Biologics, Inc (ADMA) Logo

About ADMA Biologics, Inc

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey. Address: 465 State Route 17, Ramsey, NJ, United States, 07446

ADMA Biologics, Inc News and around…

Latest news about ADMA Biologics, Inc (ADMA) common stock and company :

Best Penny Stocks to Watch as The Market Turns Bullish
22 Oct, 2021 FinancialContent
ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference
22 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 22, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that a poster presentation was made at the virtual 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization (ISIRV-WHO) Conference. The abstract and poster present

54 Biggest Movers From Yesterday
22 Oct, 2021 FinancialContent

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an ...

38 Stocks Moving In Thursday's Mid-Day Session
21 Oct, 2021 FinancialContent

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 132.3% to $23.14 following an announcement the company will ...

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock
21 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 21, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today priced its previously announced underwritten public offering of 50 million shares of its common stock at a public offering price of $1.00 per share, resulting in gross proceeds of approximately $50 million before deducting

12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 Oct, 2021 FinancialContent

Gainers Sio Gene Therapies (NASDAQ:SIOX) shares rose 13.95% to $2.45 during Thursday's pre-market session. The ...

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
21 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
21 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We're getting right into the swing of things today with a look at the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

23 Stocks Moving in Thursday's Pre-Market Session
21 Oct, 2021 FinancialContent

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 34.9% to $13.44 in pre-market trading after announcement of a proposed ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
20 Oct, 2021 FinancialContent

Gainers Tenet Healthcare (NYSE:THC) stock rose 7.06% to $70.3 during Wednesday's after-market session. Today's trading volume for ...

ADMA Biologics Announces Proposed Public Offering of Common Stock
20 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. The Company intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 15 pe

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference
19 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that a poster presentation will be made at the virtual 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization (ISIRV-WHO) Conference, which will take place on Oc

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
18 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 18, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the appointment of Young T. Kwon, Ph.D., to its Board of Directors. Dr. Kwon is a highly accomplished corporate executive in the life sciences and biotechnology space. He brings over a decade of expertise in stra

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021
04 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced on-demand access to an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan W

Adma Biologics Insider Trades $300K In Company Stock
01 Oct, 2021 Yahoo! Finance

Joseph Edelman, 10% Owner at Adma Biologics (NASDAQ:ADMA), made a large insider sell on September 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Edelman sold 260,603 shares of Adma Biologics at prices ranging from $1.12 to $1.22. The total transaction amounted to $299,236. Edelman still owns a total of 13,262,375 shares of Adma Biologics worth, $14,978,526. Adma Biologics shares are trading down 0.05% at

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021
01 Oct, 2021 Yahoo! Finance

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan Walter from the Unive

10% Owner Of Adma Biologics Sold $620K In Stock
30 Sep, 2021 Yahoo! Finance

Joseph Edelman, 10% Owner at Adma Biologics (NASDAQ:ADMA), made a large insider sell on September 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Edelman sold 500,000 shares of Adma Biologics at prices ranging from $1.23 to $1.26. The total transaction amounted to $622,500. Following the transaction, Edelman still owns 13,522,978 shares of Adma Biologics worth $15,381,035. Adma Biologics shares are trading u

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference
23 Sep, 2021 FinancialContent
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
08 Sep, 2021 FinancialContent

Gainers Kadmon Holdings (NASDAQ:KDMN) shares rose 73.39% to $9.19 during Wednesday's pre-market session. The market ...

ADMA Biologics' Aseptic Fill-Finish Machine Scores FDA Approval
08 Sep, 2021 FinancialContent

TheFDA has approvedADMA Biologics Inc's(NASDAQ: ADMA) in-house aseptic fill-finish machine, the VanRx ...

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
08 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations
08 Sep, 2021 FinancialContent
ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
02 Sep, 2021 FinancialContent
4 Stocks Insiders Are Selling
20 Aug, 2021 FinancialContent

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. ...

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
20 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
19 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

ADMA Biologics, Inc (ADMA) is a NASDAQ Common Stock listed in , ,

970x250